Experience with long-term infliximab therapy in patients with ankylosing spondylitis
The duration of continuous use of infliximab is more than 8 years in patients with ankylosing spondylitis (AS). The efficiency of the drug persists in most patients during its long-term regular therapy. Objective. To evaluate the effectiveness and safety of long-term infliximab therapy in patients w...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA PRESS LLC
2010-12-01
|
| Col·lecció: | Научно-практическая ревматология |
| Matèries: | |
| Accés en línia: | https://rsp.mediar-press.net/rsp/article/view/951 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|